(NP (NP (NP A/DT microtitre/NN assay/NN system/NN) (PP for/IN (NP glucocorticoid/NN receptors/NNS)) :/:) (NP (NP decreased/VBN receptor/NN concentration/NN) (PP in/IN (NP myocardial/JJ infarction/NN)) ./.))
(S (NP-SBJ (NP A/DT major/JJ difficulty/NN) (PP in/IN (NP (NP determination/NN) (PP of/IN (NP glucocorticoid/NN receptor/NN sites/NNS))))) (VP is/VBZ (NP-PRD the/DT (ADJP very/RB complicated/JJ) assay/NN procedure/NN)) ./.)
(S (ADVP Therefore/RB) ,/, (NP-SBJ-32 we/PRP) (VP describe/VBP (NP (NP a/DT microtitre/NN assay/NN system/NN) (PP for/IN (NP glucocorticoid/NN receptors/NNS)) (SBAR (WHNP-33 which/WDT) (S (NP-SBJ *T*-33/-NONE-) (VP is/VBZ (NP-PRD a/DT whole-cell/JJ competitive/JJ binding/NN radioassay/NN))))) (S (NP-SBJ *-32/-NONE-) (VP using/VBG (NP -LCB-3H-RCB--dexamethasone/NN) (PP as/IN (NP radioligand/NN))))) ./.)
(S (NP-SBJ (NP This/DT modification/NN) (PP of/IN (NP a/DT (ADJP previously/RB described/VBN) protocol/NN))) (VP-COOD (VP (VP-COOD (VP simplifies/VBZ (NP *RNR*-34/-NONE-)) and/CC (VP reduces/VBZ (NP *RNR*-34/-NONE-))) (NP-34 laboratory/NN work/NN)) and/CC (VP allows/VBZ (S (NP-SBJ-35 assay/NN reproducibility/NN) (VP to/TO (VP be/VB (VP controlled/VBN (NP *-35/-NONE-) (ADVP more/RBR reliably/RB))))))) ./.)
(S (S-ADV (NP-SBJ-37 *-36/-NONE-) (VP (ADVP Thus/RB) enabled/VBN (S (NP-SBJ-38 *-37/-NONE-) (VP to/TO (VP perform/VB (NP the/DT test/NN) (PP on/IN (NP multiple/JJ blood/NN samples/NNS)) (PP in/IN (NP parallel/NN))))))) ,/, (NP-SBJ-36 we/PRP) (VP investigated/VBD (NP cardiac/JJ infarction/NN patients/NNS) (PP-TMP over/IN (NP a/DT 12-day/JJ period/NN)) (S (NP-SBJ *-38/-NONE-) (VP to/TO (VP test/VB (SBAR if/IN (S (NP-SBJ-39 glucocorticoid/NN receptor/NN binding/NN) (VP is/VBZ (VP altered/VBN (NP *-39/-NONE-) (PP in/IN (NP this/DT '/`` stressful/JJ '/'' disease/NN)))))))))) ./.)
(S-COOD (S (PP-TMP On/IN (NP (NP the/DT first/JJ day/NN) (PP of/IN (NP the/DT disease/NN)))) ,/, (NP-SBJ-40 glucocorticoid/NN receptor/NN capacity/NN) (VP was/VBD (ADVP significantly/RB) (VP decreased/VBN (NP *-40/-NONE-) (PP without/IN (NP (NP alteration/NN) (PP of/IN (NP the/DT receptor-ligand/JJ affinity/NN))))))) ,/, whereas/IN (S (PP-TMP on/IN (NP days/NNS (NP-COOD (NP 4/CD) and/CC (NP 12/CD)))) (NP-SBJ (NP the/DT number/NN) (PP of/IN (NP receptor/NN sites/NNS))) (VP was/VBD (ADJP-PRD normal/JJ) (ADVP again/RB))) ./.)
(S (NP-SBJ This/DT result/NN) (VP fits/VBZ (ADVP well/RB) (PP into/IN (NP (NP the/DT general/JJ observation/NN) (PP of/IN (NP (NP stress-induced/JJ down-regulation/NN) (PP of/IN (NP immune/JJ responses/NNS))))))) ./.)
